New board appointment at iBio
This article was originally published in Scrip
iBio has appointed Major General (ret.) Dr Philip Russell to its board of directors. He served in the US Army Medical Corps from 1959-1990, pursuing a career in infectious disease and tropical medicine research.
You may also be interested in...
The company is looking at deals in the $2bn to $5bn range, CEO Paul Hudson told investors, but premiums for assets are high and Sanofi is looking at earlier-stage opportunities as a result.